Advertising disclosure: we may earn a commission when you buy through links on this site. How we make money

HomeTrials › NCT07251803

Other · Not applicable · Recruiting now

GLP1 Fasting Status and Gastric Retention Using Gastric Ultrasound

NCT07251803 · Sponsor: Medical University of South Carolina

What this trial means for you

This study is recruiting now at 1 US site. It's studying see the official record for gastric retention.

Who can joinAll sexes, 18 Years and older
Healthy volunteersNo — diagnosis required
What you'd takesee the official record
Study length~11 months overall
Planned participants150
TypeObservational (no assigned treatment)

What participants typically get: study medication (or placebo, if the trial uses one) and study-related medical care at no cost, plus close monitoring. Compensation for time and travel varies by study — ask the site. Note that in many trials you can't choose your treatment group, and some participants receive a placebo.

The study, in the sponsor's words

This study will enroll patients 18 years and older who are taking a GLP-1/GIP medication and 1) are scheduled for elective surgery and meet ASA fasting guidelines (nothing by mouth for at least 8 hours prior), or 2) scheduled elective colonoscopy and have been on a clear liquid diet for at least 24 hours prior. Participants will have a gastric ultrasound prior to surgery to measure any retained gastric contents. The purpose of this study is to determine if people taking GLP-1 receptor agonists and who fast normally are at an equal risk for having retained gastric contents after appropriately fasting for surgery, compared to patients who are on a liquid only diet for 24 hours prior to surgery.

Can you join? The exact criteria

Below is the verbatim eligibility text from the registry — bring it to your doctor; it's written for clinicians, and your own clinician is the right person to interpret it with you.

Full eligibility criteria (for you and your doctor)

Inclusion Criteria: * Age 18+ * Have taken a GLP-1 or GLP-GIP agonist medication within the past 30 days * ASA Physical Classification Status 1-3 * Fall into one of the following groups: 1. Scheduled elective surgery and meet ASA fasting guidelines (NPO for at least 8 hours prior) 2. Scheduled elective colonoscopy and have been on a clear liquid diet for at least 24 hours prior Exclusion Criteria: * Previous gastric or esophageal surgery * Abnormal gastric anatomy * Pregnancy * Unable to provide written, informed consent * Non-English speaking

Study sites by state

South Carolina

  • Medical University of South Carolina — Charleston · Recruiting now

View the official record on ClinicalTrials.gov →

Verify before you act. Medical disclaimer: content on this site is for informational purposes only and is not medical advice. GLP-1 medications are prescription drugs; always consult a licensed healthcare provider about eligibility, risks, and benefits. Trial details and enrollment status change frequently — always verify on the official registry and talk to your own clinician before contacting a study site. This page was generated from registry data and is not affiliated with the study sponsor.

Follow this trial

Get an email when our monthly digest covers enrollment changes and results for trials like this one.

Newsletter signup launches soon. (Site owner: set PUBLIC_BUTTONDOWN_USERNAME in .env to activate this form.)

Keep researching on StudyBackedHealth